Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of CHF5074 in Healthy Young Male Subjects

Inclusion Criteria: * Subject is judged to be in good health on the basis of medical history, complete physical examination including vital signs, 12-lead electrocardiogram (ECG) and standard laboratory tests. Exclusion Criteria: * Medical history (within the last 10 years) of major cardiovascular, hepatic or renal disease. * Abnormal results of liver function tests, renal function tests or thyroid tests performed at screening. * Significant allergic conditions that require medical treatment * Use of any psychoactive, recreational or prescription drug within the 4 weeks prior to study drug administration. * Use of ibuprofen, sulindac sulfide, indomethacin, flurbiprofen within 2 weeks prior to study drug administration.